Use of inferior vena cava (IVC) filters has increased dramatically in recent decades, despite
a lack of evidence that their use has impacted venous thromboembolism (VTE)‐related …

Inferior vena cava (IVC) filters have existed as a treatment option for VTE for decades.
Advances in medical technology have provided physicians with several options for devices …

Purpose To provide evidence-based recommendations on the use of inferior vena cava
(IVC) filters in the treatment of patients with or at substantial risk of venous thromboembolic …

Background Pulmonary embolism (PE) results in more than 250,000 hospitalizations
annually in the United States, with high mortality. Outcome data are limited, and reperfusion …

Pregnancy-associated high-risk pulmonary embolism (PE) is among the most frequent
causes of maternal mortality in the Western world, by causing hemodynamic instability and …

The care of patients with venous thromboembolism (VTE) is delivered via a multidisciplinary
team. The primary treatment for VTE is anticoagulation; however, placement of filter devices …

Importance Despite the absence of data from randomized clinical trials, professional
societies recommend inferior vena cava (IVC) filters for patients with venous …

The clinical management of patients with acute pulmonary embolism is rapidly changing
over the years. The widening spectrum of clinical management strategies for these patients …

Venous thromboembolism (VTE), which constitutes pulmonary embolism and deep vein
thrombosis, is a common disorder associated with significant morbidity and mortality …

Background There are few studies that have determined clinical outcomes following inferior
vena cava filter (IVCF) insertion in cancer patients hospitalized for acute deep-vein …